Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD209 | Q9NNX6 | 3/20 | 0.44 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ABL1 | P00519 | 1/20 | 0.41 |
| ▸ | ALPL | P05186 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ALPI | P09923 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALPG | P10696 | 1/20 | 0.41 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | GALK1 | P51570 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | CASP6 | P55212 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.41 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | PPARD | Q03181 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28475368 | 0.85 | TYR (0.40) | CD209SYNJ2GAAMAPTPPARG | |
| SCHEMBL1145406 | 0.78 | TYR (0.37) | CD209SYNJ2GAAMAPTPPARG | |
| SCHEMBL8720844 | 0.78 | TYR (0.37) | CD209SYNJ2GAAMAPTPPARG | |
| SCHEMBL9814366 | 0.78 | TYR (0.37) | CD209SYNJ2GAAMAPTPPARG | |
| SCHEMBL14217500 | 0.78 | PRKD3 (0.56) | CD209SYNJ2KDM4EABL1ALPL | |
| SCHEMBL2300084 | 0.78 | PRKD3 (0.56) | CD209SYNJ2KDM4EABL1ALPL | |
| SCHEMBL3924682 | 0.78 | PRKD3 (0.56) | CD209SYNJ2KDM4EABL1ALPL | |
| SCHEMBL12030336 | 0.78 | PRKD3 (0.56) | CD209SYNJ2KDM4EABL1ALPL | |
| SCHEMBL3516599 | 0.78 | PRKD3 (0.56) | CD209SYNJ2KDM4EABL1ALPL | |
| SCHEMBL13851827 | 0.78 | PRKD3 (0.56) | CD209SYNJ2KDM4EABL1ALPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3153185-B1 | COMPOSITION CONTAINING GLUCOSYLGLYCEROL FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE | BITOP AG (DE) | 2020-03-25 | — | — | EP | claimed |
| EP-3153185-A1 | COMPOSITION FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE | Bitop AG (DE) | 2017-04-12 | — | — | EP | claimed |
| EP-2328545-B1 | USE OF GLUCOSYLGLYCEROL | BITOP AG (DE) | 2015-08-05 | — | — | EP | claimed |
| EP-2869854-A1 | COMPOSITION CONTAINING ECOTINE OR HYDROXYECOTINE AS AN ACTIVE SUBSTANCES FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE | Bitop AG (DE) | 2015-05-13 | — | — | EP | claimed |
| WO-2014009118-A1 | COMPOSITION CONTAINING ECOTINE OR HYDROXYECOTINE AS AN ACTIVE SUBSTANCES FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE | BITOP AG (DE) | 2014-01-16 | — | — | WO | claimed |
| EP-2348851-B1 | COMPOSITION CONTAINING GLUCOSYLGLYCEROL | BITOP AG (DE) | 2013-05-01 | — | — | EP | claimed |
| JP-2012500781-A | — | — | 2012-01-12 | — | — | JP | claimed |
| EP-2348851-A2 | COMPOSITION CONTAINING GLUCOSYLGLYCEROL | Bitop AG (DE) | 2011-08-03 | — | — | EP | claimed |
| EP-2328545-A2 | USE OF GLUCOSYLGLYCEROL | Bitop AG (DE) | 2011-06-08 | — | — | EP | claimed |
| WO-2010049136-A2 | COMPOSITION CONTAINING GLUCOSYLGLYCEROL | BITOP AG (DE) | 2010-05-06 | — | — | WO | claimed |
| WO-2010020424-A2 | USE OF GLUCOSYLGLYCEROL | BITOP AG (DE) | 2010-02-25 | — | — | WO | claimed |
| EP-3536351-A1 | COMPOSITION FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE | Bitop AG (DE) | 2019-09-11 | — | — | EP | disclosed |
| EP-3153185-A1 | COMPOSITION FOR PROMOTING THE REGENERATION OF INJURED BODY TISSUE | Bitop AG (DE) | 2017-04-12 | — | — | EP | disclosed |
| EP-2872501-A1 | PYRIMIDINE PYRAZOLYL DERIVATIVES | Ares Trading S.A. (CH) | 2015-05-20 | — | — | EP | disclosed |
| WO-2014179528-A2 | COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS INCLUDING SUBSTITUTED NAPHTHALIMIDES SUCH AS AMONAFIDE FOR THE TREATMENT OF IMMUNOLOGICAL, METABOLIC, INFECTIOUS, AND BENIGN OR NEOPLASTIC HYPERPROLIFERATIVE DISEASE CONDITIONS | BROWN DENNIS M (US) | 2014-11-06 | — | — | WO | disclosed |
| WO-2014008992-A1 | PYRIMIDINE PYRAZOLYL DERIVATIVES | ARES TRADING S.A. (CH) | 2014-01-16 | — | — | WO | disclosed |
| WO-2014009319-A1 | INDOLINONE DERIVATIVES ANTICANCER COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-01-16 | — | — | WO | disclosed |